Fat cell therapy shows promise for stiff hands in scleroderma
NCT ID NCT07360808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a person's own fat-derived cells can improve hand function in systemic sclerosis, a disease that causes skin thickening and stiffness. 48 adults with hand problems will either get injections of these cells into their fingers or receive standard care. The goal is to see if the treatment makes daily tasks easier and safer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAND DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Fudan University
RECRUITINGShanghai, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NanFang Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an extra shot boost COVID protection in autoimmune patients?
- Can online therapy help scleroderma patients manage daily life?
- Scientists build lab models of scleroderma from Patients' blood cells
- Could blocking TL1A stop skin scarring in scleroderma? early lab study hints at possibility
- New shot aims to tame rare autoimmune disease
- CAR-T therapy takes on lupus and scleroderma in early trial